1. Home
  2. TNXP vs SFBC Comparison

TNXP vs SFBC Comparison

Compare TNXP & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • SFBC
  • Stock Information
  • Founded
  • TNXP 2007
  • SFBC 1953
  • Country
  • TNXP United States
  • SFBC United States
  • Employees
  • TNXP N/A
  • SFBC N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • SFBC Savings Institutions
  • Sector
  • TNXP Health Care
  • SFBC Finance
  • Exchange
  • TNXP Nasdaq
  • SFBC Nasdaq
  • Market Cap
  • TNXP 118.2M
  • SFBC 127.6M
  • IPO Year
  • TNXP N/A
  • SFBC N/A
  • Fundamental
  • Price
  • TNXP $18.83
  • SFBC $50.40
  • Analyst Decision
  • TNXP Strong Buy
  • SFBC
  • Analyst Count
  • TNXP 2
  • SFBC 0
  • Target Price
  • TNXP $585.00
  • SFBC N/A
  • AVG Volume (30 Days)
  • TNXP 573.9K
  • SFBC 4.0K
  • Earning Date
  • TNXP 05-20-2025
  • SFBC 04-29-2025
  • Dividend Yield
  • TNXP N/A
  • SFBC 1.51%
  • EPS Growth
  • TNXP N/A
  • SFBC N/A
  • EPS
  • TNXP N/A
  • SFBC 1.95
  • Revenue
  • TNXP $10,094,000.00
  • SFBC $36,560,000.00
  • Revenue This Year
  • TNXP $12.17
  • SFBC N/A
  • Revenue Next Year
  • TNXP $789.15
  • SFBC N/A
  • P/E Ratio
  • TNXP N/A
  • SFBC $25.86
  • Revenue Growth
  • TNXP 29.94
  • SFBC N/A
  • 52 Week Low
  • TNXP $6.76
  • SFBC $39.25
  • 52 Week High
  • TNXP $672.00
  • SFBC $55.99
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 53.35
  • SFBC 47.40
  • Support Level
  • TNXP $18.55
  • SFBC $50.26
  • Resistance Level
  • TNXP $21.99
  • SFBC $51.33
  • Average True Range (ATR)
  • TNXP 1.53
  • SFBC 0.49
  • MACD
  • TNXP 0.22
  • SFBC -0.03
  • Stochastic Oscillator
  • TNXP 58.64
  • SFBC 22.82

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

Share on Social Networks: